<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02435303</url>
  </required_header>
  <id_info>
    <org_study_id>MVsurgery_PAH</org_study_id>
    <nct_id>NCT02435303</nct_id>
  </id_info>
  <brief_title>Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)</brief_title>
  <acronym>SUPERIOR</acronym>
  <official_title>Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Sildenafil is effective in the treatment of
      sustained pulmonary artery hypertension after corrected mitral valve disease.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Six Minutes Walk Distance</measure>
    <time_frame>baseline and six months</time_frame>
    <description>unit of measure : meter (m)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Borg dyspnea score</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity by cardiopulmonary exercise test</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional area change of right ventricle measured by echocardiography</measure>
    <time_frame>six months</time_frame>
    <description>unit of measure : percent (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary vascular resistance (PVR) measured by cardiac catheterization</measure>
    <time_frame>six months</time_frame>
    <description>unit of measure : wood unit (WU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic pulmonary artery pressure measured by cardiac catheterization</measure>
    <time_frame>six months</time_frame>
    <description>unit of measure : pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean pulmonary artery pressure measured by cardiac catheterization</measure>
    <time_frame>six months</time_frame>
    <description>unit of measure : pressure (mmHg)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Hypertension, Pulmonary</condition>
  <condition>Diseases of Mitral Valve</condition>
  <arm_group>
    <arm_group_label>Sildenafil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sildenafil 20mg tid for six months (* consider open-label extension study for 1 year)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablets do not contain an active ingredient but are identical in shape with each active tablet of Sildenafil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <arm_group_label>Sildenafil</arm_group_label>
    <other_name>Viagra, Revatio, others</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New York Heart Association Functional class (NYHA Fc) ≥ 2 dyspnea which was sustained
             till one year after the previous mitral valve surgery (repair or replacement)

          -  TR Vmax ≥ 3.5m/s by echocardiography

          -  Normal left ventricle ejection fraction (EF ≥ 50%)

          -  Pulmonary vascular resistance ≥ 3 Wood Unit or diastolic pressure gradient ≥ 7mmHg by
             cardiac catheterization

        Exclusion Criteria:

          -  Other valve disease more than moderate degree (ex. aortic stenosis, aortic
             regurgitation)

          -  Liver cirrhosis

          -  Chronic renal failure with serum creatinine ≥ 1.7mg/dL

          -  Lung disease (ex. chronic obstructive pulmonary disease, Asthma)

          -  Thyroid dysfunction

          -  Other causes which can lead to pulmonary hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong-Min Song</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2015</study_first_submitted>
  <study_first_submitted_qc>May 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2015</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Jong-Min Song</investigator_full_name>
    <investigator_title>Professor, University of Ulsan College of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

